Abstract 2430 Why No Corrigenda Available for Endoplasmic Reticulum-Associated Abeta-Binding Protein/Abeta-Binding Alcohol Dehydrogenase Studies?
Year: 2024
Type: conference-abstract
Abstract: The mitochondrial type 10 hydroxysteroid dehydrogenase (HSD10) was also known as endoplasmic reticulum-associated protein (ERAB) or so-called Abeta-binding Alcohol Dehydrogenase (ABAD) published in the Nature and Science journal, respectively (see OMIM300256 '17beta-hydroxysterod dehydrogenase X' and OMIM#300438 'HSD10 mito- chondrial disease'). According to human 17beta-HSD10 studies, the structure or function reported for the ERAB/ABAD were imperfect (see He XY et al. Int. J. Mol. Sci. 24, 8487, 2023 and JBC 273, 10741, 1998; JBC 274, 15014, 1999; BJ 345, 139, 2000; BBA, 1484, 267, 2000; MCE 171, 89, 2001; EJB268, 4899, 2001; Mol Brain Res, 99, 46, 2002; JSBMB87, 191, 2003; FEBS J 272, 4874, 2005; MCE 229, 111, 2005; EMIDDT 6, 95, 2006; MGM 91, 115, 2007; MGM92, 36, 2007; EJHG 19, 123, 2011; IBD 19, E23, 2013; J Alz Dis 62, 665, 2018; MCE 489, 92, 2019; AGG 1, 1005, 2021; JAD88, 1487, 2022; Int J Mol Sci 24, 17604, 2023). Unfortunately, authors of the ERAB/ABAD reports have owe their readers necessary corrections forever. More shamelessly, a member of the JBC editorial board attempted to cover this immoral problem as an 'old issue'?! The NIH funding units that had already supported the ERAB/ABAD studies should take actions to avoid a continuously spread of confusions in readers of those prestigious journals. We believe that the relief of necessary corrigenda should be considered as a basic standard for the ethnicity of the scientific publications where the incorrect information appeared. NYS Office for People with Developmental Disabilities.
Source: Journal of Biological Chemistry
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,800
OpenAlex ID: W4393167644